BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Nektar Therapeutics Reports First Quarter 2021 Financial Results

  Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the first quarter ended March 31, 2021.

  May 6, 2021

   · 

  12 min read
• Business

  Endo Reports First-Quarter 2021 Financial Results And Updates 2021 Financial Guidance

  Endo International plc reported financial results for the first-quarter ended March 31, 2021.

  May 6, 2021

   · 

  28 min read
• Business

  Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

  Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), today reported financial results for the quarter ended March 31, 2021 and provided a business update.

  May 6, 2021

   · 

  9 min read
• Business

  Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights

  Quarter highlights include FDA approval, launch and early market penetration of LUPKYNIS™ as the first approved oral therapy for lupus nephritis (LN)

  May 6, 2021

   · 

  14 min read
• Business

  Avinger Reports First Quarter 2021 Financial Results

  Avinger, Inc., a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease, reported results for the first quarter ended March 31, 2021.

  May 6, 2021

   · 

  12 min read
• Latest innovation from orthopedic tool manufacturer improves efficiency and speed of skeletal traction

  A new kit to improve the efficiency and speed of trauma centers in performing skeletal traction, while maintaining sterility, has launched from Arbutus Medical, a global leader in converting hardware power drills into FDA-compliant orthopedic power tools.

  May 6, 2021

   · 

  3 min read
• Drug Development

  EVERSANA advances commercialization readiness as Humanigen announces publication of phase 3 randomized double-blind placebo-controlled study demonstrating the efficacy and safety of lenzilumab™ in newly hospitalized COVID-19 patients

  EVERSANA, a pioneer of next generation services to the global life sciences industry, today congratulated its partner, Humanigen, on the publication of positive results from the lenzilumab LIVE-AIR Phase 3 study in newly hospitalized COVID-19 patients.

  May 6, 2021

   · 

  3 min read
• Genetown

  Fourth Annual Best of Benchmark Award Winners Announced

  Trinity Life Sciences, a leader in global life science commercialization solutions, announced the winners of the TGaS Best of Benchmark Awards.

  May 6, 2021

   · 

  3 min read
• Business

  Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update

  Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on womens intimate health, today announced that it will report its first quarter 2021 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 13, 2021.

  May 6, 2021

   · 

  4 min read
• Deals

  GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients

  GE Healthcare today announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare

  May 6, 2021

   · 

  9 min read